I'd like to acknowledge a few books that opened my eyes to this controversial but fascinating field of research.
The first is The Virus and the Vaccine, a fascinating true story of the contamination of the polio vaccine with a cancer-causing monkey virus.
The second is Dr. Mary's Monkey. Although I didn't use this book as a source, it's a thrilling story in its own right, and weaves together the JFK assassination, the contaminated polio vaccine scandal, and a secret project to develop a bio-weapon to kill Fidel Castro.
Lastly I owe much of this research to the indispensable Vaccine Safety Manual for Concerned Families and Health Practitioners. The thousands of references provided have proved to be a veritable gold mine.
The EZ-HT Experiment
Another WHO/CDC catastrophe concerns the measles vaccine.
Most infants under five months are protected from measles by maternal antibodies, and standard measles vaccines are ineffective in babies under nine months. Since measles death rates are higher in Third World countries, authorities decided to create a “high-titer” vaccine to target this 5-9 month age range.
Beginning in the 1980s, they tested the Edmonston-Zagreb (EZ-HT) strain on Mexican and Gambian babies 4-6 months old.
The same high-titer vaccine continued to be administered in Guinea-Bissau, Togo, Senegal, Bangladesh, Haiti, and impoverished minority communities in Los Angeles, California.
The public was told that EZ-HT “produces a better immunological response than standard vaccines,” but studies had been conducted that concluded the vaccine was unsafe for infants, including the following: Child mortality after high-titre measles vaccines: prospective study in Senegal.
The study concluded, quite unequivocally, that “The higher risk of death in the two high-titre vaccine groups remained significant in multivariate analyses. These findings suggest a need to reconsider the use of high-titre measles vaccines early in life in less developed countries.”
Babies who received SW-HT died at a rate that was 51% higher than those who received the standard vaccine...nearly 50 excess deaths for every 1000 babies vaccinated. EZ-HT was much more potent, contributing to a rate that was 80% higher, contributing to 75 excess deaths for every 1000.
Strikingly, according to the previously cited study published by Lancet in 1991, 1 in every 6 babies vaccinated with EZ-HT died within three years. Unfortunately, even this didn't deter enthusiasts of the high-titer shot.
Even though the WHO and the CDC knew about the high mortality rate already being associated with the vaccine, they still considered the data “preliminary.”
Before the trials finished, nearly 1500 minority babies had been given the experimental vaccine, according to this 1996 LA Times article:
We now know that the CDC lied about the study on numerous occasions.
The “informed consent” form provided to parents violated internationally accepted ethical codes of conduct regulating human experimentation. Parents were not informed that EZ-HT was unlicensed in the US.
Parents were told that millions of doses of EZ-HT had been used in Europe. But the LA babies were actually receiving a vaccine that was up to 500 times more potent.
The CDC said the communities targeted for the vaccine were those hit hardest by recent measles outbreaks. According to data obtained from the Los Angeles County Department of Health, these communities were not the hardest hit. Journalist Keidi Obi Awadu, in his Outrage!, documented that “three three regions chosen to receive the experimental shots were predominantly Black and Hispanic.” Furthermore, “several mixed-race and White communities harder hit by the recent outbreak of measles were not chosen to participate in the study.”
Although the CDC claimed no children were adversely affected, one baby did die from a rare bacterial disease. According to Awadu, several children “experienced what parents are describing as long-term immune system impairment, seizures and other acute conditions consistent with vaccine-induced injury.”
Stephen Hadler of the CDC claimed the babies died in earlier studies because they didn't have access to adequate health care. However, one of the more important findings of the Senegal study was “the three vaccine groups were comparable as regards various social, family, and health characteristics. Intensive medical care was provided during the project.”